Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT

Ann Hematol. 2023 Feb;102(2):473-475. doi: 10.1007/s00277-022-05047-8. Epub 2022 Nov 24.

Haimin Sun¹, Han Yan², Zeying Yan¹, Yongmei Zhu², Guang Yang², Sujiang Zhang^{3

4}

¹ Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Ruijin Road II 197, Shanghai, China.
² Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Ruijin Road II 197, Shanghai, China.
³ Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Ruijin Road II 197, Shanghai, China. [email protected].
⁴ Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Ruijin Road II 197, Shanghai, China. [email protected].

No abstract available

Publication types